Research into weight-loss drugs tipped for Nobel as award week opens
This week marks the start of the 2026 Nobel Prize season, with the medicine prize set to be announced on Monday. Researchers studying hormones that regulate appetite are in the spotlight, as the work leading to weight-loss drugs like Ozempic and Mounjaro could earn a Nobel. The GLP-1 hormone, discovered through microbiome research and released by the intestine after eating, is a significant factor in these drugs' success.
Experts believe GLP-1 is the top contender for the Nobel, given its global clinical impact. Other potential winners include Canadian endocrinologist Daniel Drucker, Danish physician Jens Juul Holst, and American chemist Svetlana Mojsov, all recognized for their contributions to the field.
Written by urgent.news from Gulf News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
